throbber
(19) Japan Patent Office (JP)
`(12) Patent Gazette (A)
`(11) Japanese Patent Application Publication
`Number HEI 8 — 231391
`
`(51) Int. Cl 4 Classification Symbol Internal No.
`A23L 1/42
`8412—4B
`
`A61 K 9/48
`
`31/355
`
`ADL
`
`6742—4C
`
`7330—4C
`
`(43) Publication Date August 13, 1985
`
`(54) Title of Invention
`
`(72) Inventor
`(72) Inventor
`(71) Applicant
`
`Request for Review Unrequested Number of Claims 1 (Total 2 Pages)
`
`Nutritional Supplement
`(21) Application Number
`Sho 59 — 10625
`(22) Application Date
`January 24, 1984
`Motuski Kenji
`Tokyo-to, Nakano-ku, UenoMiya 4 Choume 9 Ban 6 Go
`Fukuoka Ryuu
`Tama-shi Nagayama 4 No 4 No 21 No 304
`Honen Seiyu Co. Ltd.
`Tokyo-to, Chiyoda-ku, Otemachi 1 Choume 2 Ban 3 Go
`
`Specification
`1. Title of Invention
`
`Nutritional supplement
`2. Scope of Claims
`(1) A nutritional supplement being contained inside
`a gelatin capsule and comprising a nutritional liquid
`being formed by melting vitamin E, soybean
`lecithin in an oil having high eicosapentaenoic acid
`content.
`
`(2) A nutritional supplement of claim 1 wherein the
`oil having high eicosapentaenoic acid content is a
`sea animal oil such as pilchard oil, mackerel oil,
`cuttlefish oil, krill oil, or mink oil.
`3. Detailed Explanation of the Invention
`The present invention relates to a new nutritional
`supplement having as its primary ingredients
`vitamin E, soybean lecithin, and an oil having high
`eicosapentaenoic acid content. In recent years, the
`demand for nutritional supplements has greatly
`increased due to factors such as (1) lack of
`nutritional balance brought about by a rich food
`culture, (2) pickiness and lack of food diversity
`caused by a selective food palette, (3) lack of
`nutrition brought about by a breakdown in balance
`of nutrition and health, exercise, and energy, and (4)
`the necessity for supplementary nutrition to
`correspond to an aging population. In particular, the
`desire to stem adult disease by the improvement of
`food life is strong, so people enjoy eating nutritional
`supplements.
`
`The present invention arises out of the
`aforementioned nutritional needs and its object is to
`provide a new nutritional supplement from the
`combination of vitamin E, which (1) prevents the
`aging of cells, (2) lowers cholesterol and prevents
`the hardening of arteries, (3) prevents the
`occurrence of liquid fatty deposits and encourages
`cell life, (4) cleans and washes blood vessels and
`prevents brain or heart blood clots; soybean lecithin,
`which (1) encourages the absorption of vitamin E
`and eicosapentaenoic acid, (2) reduces cholesterol
`and prevents hardening of blood vessels and oil
`having high eicosapentaenoic acid content, which is
`effective anti-platelet aggregation, making it an
`anti-coagulant and acts to prevent the hardening of
`blood vessels.
`
`In other words, the present invention is a
`nutritional supplement consisting of vitamin E and
`soybean lecithin melted in an oil having high
`eicosapentaenoic acid content in liquid form
`inserted into a gelatin capsule.
`
`As for the vitamin E used in the present invention,
`items obtained by publicly known methods such as
`concentration by chromatography or molecular
`distillation of plant oils are appropriate, but the
`method of production thereof is not limited, and the
`source of energy is also not limited.
`Vitamin E is included in great amounts in
`safflower oil, rice oil, corn oil, and other oil from
`water dwelling plants. However, the concentration
`
`-363-
`
`000001
`
`Petition for Inter Partes Review
`Of U.S. Patent 8,278,351
`Exhibit
`
`ENZYMOTEC - 1014
`
`AKER877|TC00804540
`
`000001
`
`

`
`of the oil is at most 0.3%, so using any of these as-is is not desirable.
`
`Also, soybean fatty substance containing soybean oil obtained by
`dehydrating and drying gum produced by the production of soybean
`gum is generally acceptable for the soybean lecithin used in
`conjunction with vitamin E, but it is also acceptable to use lecithin
`that has been sugared and concentrated via acetone or alcohol, and it
`is also possible to use separated lecithin that contains little of no
`keratin.
`
`effects will not be sufficient. A nutritional supplement
`formed by melting vitamin E and soybean lecithin in oil
`The amount of vitamin E included in the present invention must be at with a high concentration of eicosapentaenoic acid, within
`least 1% of the liquid included in the capsule. If less than this
`the scope wherein it is possible to maintain the relative
`concentration is achieved the activity of the vitamin in the body is
`levels of the various substances, may be diluted with
`reduced, and the benefits of vitamin E cannot be achieved.
`safflower oil, rice oil, corn oil, soybean oil, or seaweed oil
`or other sea life oil. Mixed oil obtained in this way is
`inserted into a gelatin capsule under normal circumstances.
`As one example of the method of sealing the substance in
`a capsule, the mixed liquid will be sealed in a gelatin
`capsule in a certain amount, the gelatin formed by melting
`gelatin, glycerin, and water. After that, the entry hole will
`be heated and sealed to create the nutritional substance of
`the present invention.
`The form of the gelatin capsules may be spherical or in
`the form of a rugby ball.
`This soybean lecithin must be present in the liquid that is inserted
`Because the nutritional supplement of the present
`into the capsule in a concentration of at least 1%. As noted before, if
`invention obtained in this way contains vitamin E which
`the concentration falls below this level the effects of the substance
`prevents the aging of cells, lowers cholesterol numbers,
`will not be sufficient. In addition, for oil with a high concentration of
`prevents excess fat deposits, and has other positive side
`eicosapentaenoic acid (C20 : 5) that has vitamin E and soybean
`effects, as well as contains soybean lecithin, which acts to
`lecithin dissolved within it, an oil with a eicosapentaenoic acid
`lower cholesterol and promote the absorption of
`content of 8% or higher may be used, such as that found in sea
`eicosapentaenoic acid, and contains eicosapentaenoic acid,
`animal oils such as pilchard oil, mackerel oil, cuttlefish oil, krill oil,
`or mink oil, or an oil that was derived from one of the above and had which acts to prevent the hardening of blood vessels, the
`was concentrated with respect to eicosapentaenoic acid content.
`combined effects of the various ingredients act to reduce
`the cholesterol levels in the blood, prevent high blood
`pressure, reduce fat, and promote heart and brain function
`in brain and heart medical patients, and acts to treat and
`prevent adult circulatory diseases, and as such can be said
`to function as a nutritional supplement.
`
`The concentration of oil having a high concentration of
`eicosapentaenoic acid in the present invention must be at least 10%
`of the volume of liquid in the capsule. If this concentration is not
`achieved then the effect of the oil in the body will be lacking and as
`noted before the
`
`Below, the embodiments of the present invention are explained.
`Embodiment 1.
`
`25 parts vitamin E and 25 parts soybean lecithin are dissolved into
`50 parts fish oil (containing 16% eicosapentaenoic acid), heated to
`around 60 degrees Celsius, and dried.
`Then 60 parts gelatin, 30 parts glycerin, and 10 parts water are
`uniformly mixed, are made to take a film like form, are poured into a
`300 milligram capsule and put into a gelatin container. The
`aforementioned compound is poured into this container, the entry
`point is heat sealed, and the nutritional supplement of the present
`invention is formed.
`
`Embodiment 2
`
`30 parts vitamin E by weight and 30 parts soybean lecithin are
`dissolved into a 1:1 mixture of safflower oil and market concentrated
`
`eicosapentaenoic acid oil (produced by Nippon Yushi Co. Ltd., Sun
`Omega, and containing 25% eicosapentaenoic acid), the mixture
`being 40 parts. The liquid is heated to around 60 degrees Celsius and
`dried.
`
`Then 60 parts gelatin, 30 parts glycerin, and 10 parts water are
`uniformly mixed, are made to take a film like form, are poured into a
`300 milligram capsule and put into a gelatin container. The
`aforementioned compound is poured into this container, the entry
`point is heat sealed, and the nutritional supplement of the present
`invention is formed.
`
`-364-
`
`°°°°°2
`
`AKER877|TC00804541
`
`000002

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket